The Price of Platform Agility Fifty million dollars just landed in Moderna’s accounts, courtesy of the Coalition for Epidemic Preparedness Innovations (CEPI), earmarked for the early-stage development of an mRNA vaccine against Bundibugyo ebolavirus. Read More
